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Edited by Robert B. RussellAbstract DNA methylation plays a key role in the regulation of
gene expression. The most common type of DNA modiﬁcation
consists of the methylation of cytosine in the CpG dinucleotide.
At the present time, there is no method available for the predic-
tion of DNA methylation sites. Therefore, in this study we have
developed a support vector machine (SVM)-based method for the
prediction of cytosine methylation in CpG dinucleotides. Initially
a SVM module was developed from human data for the predic-
tion of human-speciﬁc methylation sites. This module achieved
a MCC and AUC of 0.501 and 0.814, respectively, when evalu-
ated using a 5-fold cross-validation. The performance of this
SVM-based module was better than the classiﬁers built using
alternative machine learning and statistical algorithms including
artiﬁcial neural networks, Bayesian statistics, and decision trees.
Additional SVM modules were also developed based on mamma-
lian- and vertebrate-speciﬁc methylation patterns. The SVM
module based on human methylation patterns was used for gen-
ome-wide analysis of methylation sites. This analysis demon-
strated that the percentage of methylated CpGs is higher in
UTRs as compared to exonic and intronic regions of human
genes. This method is available on line for public use under the
name of Methylator at http://bio.dfci.harvard.edu/Methylator/.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Prediction1. Introduction
In vertebrates, the methylation of cytosine is the most fre-
quent endogenous modiﬁcation of DNA. This modiﬁcation
consists of the addition of a methyl group to carbon-5 in the
pyrimidine ring of cytosine, and is mediated by speciﬁc
DNA-methyl transferases [1–3]. The majority of the 5 0-methyl-
cytosine is present in 5 0-CpG-3 0 dinucleotides [4]. Methylation
in non-CpG sequences is less frequent, though it can add up to
15–20% of total 5 0-methylcytosine [5]. CpGs are present at anAbbreviations: ACC, accuracy; AUC, area under curve; MCC, Mat-
thews correlation coeﬃcient; SE, sensitivity; SP, speciﬁcity; RBF,
radial basis function; SVM, support vector machine
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doi:10.1016/j.febslet.2005.07.002average of one per 80-dinucleotides throughout most parts of
the genome. However, there are regions within the genome
where CpGs are around ﬁve times greater than average. These
regions are known as CpG islands [6] and comprise 1–2% of
the genome. CpG islands have a high G + C content (greater
than 50%), and a size ranging from 200 bp to several thousand
base pairs [6,7]. The CpG islands are present in promoter and/
or exonic regions of 50–60% of mammalian genes, and are
mostly non-methylated. In contrast, CpGs outside CpG island
are mostly methylated [3,8].
DNA methylation has been linked to the repression of gene
expression through two main mechanisms. On the one hand,
methylation of CpGs may disrupt the binding of certain tran-
scription factors [9–11], and on the other, it promotes the bind-
ing of speciﬁc 5-methylcytosine binding proteins and other
structural proteins which results in packing of the DNA into
a structure that is inaccessible to transcription factors. Thus,
it has been suggested that patterns of methylation may com-
partmentalize the genome into transcriptionally active (non-
methylated) and non-active regions (methylated) [1,12,13].
DNA methylation can alter the ﬂow of the genetic information
and reprogram genome function [14], and therefore it has been
recognized as a major epigenetic modiﬁcation. Genomic meth-
ylation patterns in non-dividing somatic diﬀerentiated cells are
generally stable and heritable. However, there are instances
where methylation patterns undergo signiﬁcant changes that
alter the phenotype. For example, genome-wide changes in
methylation patterns occur during developmental embryogen-
esis and in stem cell diﬀerentiation [14,15]. There is also evi-
dence that methylation patterns change in CpG islands of
gene promoters during aging [16–18]. Although the aforemen-
tioned alteration in DNA methylation patterns are physiolog-
ical, aberrant patterns of methylation have been also found in
various diseases [19], most notoriously in cancers [20]. Thus, in
cancer cells, the usual pattern of DNA methylation is reversed,
with hypermethylation of CpG islands in promoter genes and
overall exonic hypomethylation [21–23].
Clearly, the determination of DNA methylation is function-
ally relevant. A high throughput method for experimental
determination of overall DNA methylation has been success-
fully accomplished using gene expression data [24]. However,
identiﬁcation of the speciﬁc methylated sites in the DNA can
only been accomplished through laborious and time consum-
ing experiments. Therefore, computational identiﬁcation of
DNA methylation sites may provide a good alternative.
Unfortunately, DNA methylation sites are poorly conserved,blished by Elsevier B.V. All rights reserved.
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we have developed a method for the prediction of DNA meth-
ylation in CpG dinucleotides using support vector machine
(SVM). The method can predict the human-speciﬁc DNA
methylation sites with good accuracy outperforming alterna-
tive prediction algorithms including artiﬁcial neural networks
(ANN). The method has been implemented online as ‘‘Methyl-
ator’’ at the site http://bio.dfci.harvard.edu/Methylator hosted
by the Dana-Farber Cancer Institute. The development of this
SVM-based method, the evaluation of its predictive perfor-
mance, and its application to the prediction of methylation
sites in the human genome will be discussed in the subsequent
sections of the manuscript.2. Material and methods
2.1. Datasets
Methylated as well as non-methylated CpG dinucleotide sequences
were obtained from the MethDB database [25]. MethDB is a curated
database of experimentally determined methylated DNA fragments
(patterns). The database contains a total of 4996 methylation patterns
form various sources ranging from plants to humans. For training of
SVM the datasets were obtained by fragmenting the MethDB sequence
patterns into overlapping fragments of ﬁxed length (window size).
Fragments with a methylated cytosine in the center were considered
as positives, whereas fragments with non-methylated cytosine in the
center were considered as negatives. Only unique fragments (non-
redundant) were considered to avoid overtraining and biased predic-
tions. Various datasets were generated by varying the window size
from 9 to 89 nucleotides. Each nucleotide was represented using con-
ventional binary sparse encoding. For example, adenine is represented
by 10000, cytosine by 01000 and so on. The last bit is used to handle
the incomplete windows in the initial and terminal part of the
sequences.
2.2. Support vector machine (SVM)
SVM is a technique based on statistical learning theory quite popu-
lar in pattern recognition and regression problems. Here, SVM imple-
mentation was achieved using the freely downloadable package
SVM_light (http://www.joachims.org) for non-commercial or aca-
demic use [26]. This package has options to select or deﬁne a kernel
as well as varying the kernel parameters. Training sets consisted of
N fragments or input vectors {x1,x2,x3, . . .,xi, . . .,xN} and known la-
bels for each fragment {y1,y2,y3, . . .,yi, . . .,yN}, indicating whether
the fragment is methylated or not (yi{+1, 1}). The xi corresponds
to the nucleotide sequence represented by a 5 binary sparse code (de-
ﬁned in Section 2.1). During training, a new value x is assigned to each
fragment by the SVM according to Eq. (1)
Z
ðxÞ ¼ sign
XN
i¼1
Y iai; kðxi; xÞ þ b
 !
; ð1Þ
where k is the kernel function that deﬁnes the feature space; b is the
bias value, i is the number obtained by solving the quadratic program-
ming problem that gives the maximum margin hyper plane. The
trained SVM will give a score for each conﬁguration varying between
1.5 and 1.5. The cytosine residue is assigned to be methylated if the
predicted score is larger than the threshold.
2.3. Alternative machine learning and statistical algorithms
In this study, we have also approached the prediction of methylation
sites using a set of statistical and machine learning techniques as alter-
natives to SVM. These techniques included ANN, Bayesian statistics,
logistic regression, decision trees and the K-nearest neighbors based
algorithms.
ANN. The ANN implementation was achieved using the freely
downloadable package SNNS version 4.2 from Stuttgart University
[27]. In the present study, a feed-forward back-propagation network
with a single hidden layer was used. The network had an input windowof 39 residues and 13 units in a single hidden layer. The data was pro-
vided to the network in sparse binary format (as described elsewhere).
At the start of each simulation, the weights were initialized with ran-
dom values. The training of the network was carried out using error
back-propagation with a sum of square error function [28]. The mag-
nitude of the error sum in the test and training set was monitored in
each cycle of the training. The ultimate number of cycles (700 in this
case) was determined when the network converges. During the testing
of the network, the output of the network was compared with an arbi-
trarily deﬁned cutoﬀ value. If the output was greater than the cutoﬀ,
then that fragment was considered to be methylated, whereas if it
was lower, it was considered as a non-methylated. The cutoﬀ was set
to the value where sensitivity and speciﬁcity are approximately equal
(deﬁned below).
Waikato environment for knowledge analysis (Weka). Weka is a
java package providing an environment for implementation of a large
number of machine learning and statistical algorithms [29]. In the
present study, we have implemented four classiﬁers based on the fol-
lowing algorithms: (i) naı¨ve bayes, (ii) logistic regression, (iii) J48 and
(iv) lazy IBk. The naı¨ve bayes is based on the Bayesian theorem
which is particularly useful when the dimensionality of the input is
high [30]. Logistic regression is a variation of the ordinary regression
frequently used when the observed outcome is restricted to two val-
ues [31]. J48 is a classiﬁcation algorithm that generates a decision tree
by recursive partitioning of the data [32]. IBk is an algorithm based
on K-nearest-neighbors that employs distance matrices to classify the
data [33].
The data for all these classiﬁers was represented in attribute relation
function format, consisting of the list of all instances with the attribute
value for the instances (yes for methylated fragments and no for non-
methylated fragments) separated by commas. Provided with a training
and testing set, Weka generates a confusion matrix summarizing the
classiﬁcation results.2.4. Evaluation of the predictive performance of the methylation
classiﬁers
The performance of all classiﬁers was evaluated using a standard 5-
fold cross-validation. In the 5-fold cross-validation, the dataset was
randomly partitioned into 5 subsets. Each subset had an equal ratio
of methylated and non-methylated fragments. Each classiﬁer was
trained 5 times, each time using 4 subsets for training and remaining
the 5th subset for testing. In this way, 5 models were generated during
cross-validation. The ﬁnal prediction performance was obtained by
averaging the results obtained from each model. Prediction perfor-
mance was determined by measuring the threshold-dependent param-
eters sensitivity (SE), speciﬁcity (SP), accuracy (ACC) and Matthews
Correlation coeﬃcient (MCC). The SE, SP, ACC and MCC parame-
ters were calculated using Eqs. (2)–(5), respectively,
SE ¼ TP=ðTPþ FNÞ; ð2Þ
SP ¼ TN=ðTNþ FPÞ; ð3Þ
ACC ¼ ðTPþ TNÞ=ðTPþ TPþ FPþ FNÞ; ð4Þ
MCC ¼ ðTP  TNÞ  ðFN  FPÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðTPþ FNÞ  ðTNþ FPÞ  ðTPþ FPÞ  ðTNþ FNÞp ; ð5Þ
where TP are true positives (methylated sites predicted as methylated);
FN are false negatives (methylated sites predicted as non-methylated);
TN are true negatives (non-methylated sites predicted as non-methyl-
ated) and FP are false positives (non-methylated sites predicted as
methylated).
Performance of the classiﬁers was also evaluated in a threshold inde-
pendent manner by carrying out a relative operating characteristic
(ROC) analysis. The ROC curves were generated by plotting the func-
tion SE versus 1-SP for various prediction thresholds [34]. The area un-
der the ROC curve (AUC) provides a single measure of overall
prediction accuracy. Values of AUC between 0.7 and 0.9 indicate good
prediction accuracy, and above 0.9 indicate excellent prediction accu-
racy. Values of AUC between 0.5 and 0.7 indicate poor accuracy [34].
For the SVM-based modules, in addition to the 5-fold cross-valida-
tion, a leave oneout cross-validation (LOOCV)was alsoused to evaluate
the performance. In LOOCV, the classiﬁer is successively generated on
n  1 samples and tested on the remaining one. This is repeated n times
so that every sample is left out once. The performance of the modules is
judged by computing the AUC value as indicated above.
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Most common DNA methylation occurs in cytosine of 5 0-
CpG-3 0 dinucleotides. CpGs are present through the genome
but their abundance is greater in regions known as CpG is-
lands, which are usually located in the promoters and exons
of most genes. Despite the key role DNA methylation plays
in regulating gene expression and in reprogramming genome
function, until now there is no method that can predict
DNA methylation sites. This is due to fact that methylation
sites patterns are very diﬀuse and cannot be identiﬁed by tra-
ditional pattern-based search algorithms. Therefore, in order
to identify the complex signature for methylation of cytosine
in CpGs, we have used SVM [35]. SVM is a successful learning
technique that can outperform other machine learning tech-
niques like ANN and K-nearest neighbors methods. Among
the many attractive features of SVM algorithm are the absence
of local minima, its speed and scalability, and its ability to con-
dense information contained in the training set. It is known
that methylation patterns vary from species to species [36].
Not surprisingly, methylated bacterial CpG islands can be rec-
ognized by the human immune system as foreign entities, thus
triggering a powerful innate immune response [37]. Under
these considerations, SVM-based methylation modules were
implemented with consideration given to the taxonomic kin-
ship of the sources of the methylation data. Thus, we have de-
rived independent SVM modules from methylated patterns
derived from human, mammalian and vertebrates (marked
by a solid dot in Fig. 1). The mammalian data included meth-
ylation patterns from human, mouse and rat whereas verte-
brates also included methylation data from other organisms
like domestic chickens, etc. The datasets for training classiﬁers
were prepared as indicated in Section 2 of the manuscript. We
failed to develop classiﬁers from mouse or rat methylation
data due to the low number of representative methylation pat-
terns (<200).
3.1. SVM module for the prediction of methylation sites in
human
For the prediction of human methylation sites, a SVM mod-
ule was developed based on 2839 methylation patterns corre-
sponding to DNA fragments from diﬀerent tissues like liver,
blood, kidney, epidermis, etc. SVM was trained with patterns
of ﬁxed length with methylated and non-methylated CpGFig. 1. Data structure for training SVM modules. Figure shows the
taxonomic levels for which methylation patterns were obtained.
Number indicate the methylation patterns available at the particular
taxonomic levels. The SVM modules were developed for taxonomic
groups marked with a solid dot.dinucleotides in the center derived from human methylation
data. In order to investigate the eﬀect of ﬂanking nucleotides
in specifying the methylation, we trained SVM with sequence
fragments (window size) varying from 9 to 89 nucleotides
(see Section 2 for details). With a window size of 9 nucleotides
(4 nucleotides at each side of the central cytosine) the SVM
module performed very poorly. Thus, the determined AUC va-
lue was 0.56, indicative of a nearly random prediction. Increas-
ing the window size from 9 to 19 dramatically improved the
predictive performance of the module (AUC 0.73). Also,
increasing the window size from 19 to 39 led to a signiﬁcant
improvement of the performance of the module, as judged
by the augment of the AUC value from 0.70 to 0.82 (Fig. 2).
However, further increases of the window size did not lead
to any signiﬁcant improvement in the ACC of the predictions.
Consequently, a window size of 39 was selected as the optimal
(set as default) for the prediction of cytosine methylation in
CpG dinucleotides. At the default threshold (0.4), where
the SE and SP of the predictions are nearly equal, the module
is able to achieve an ACC and MCC of 75% and 0.504, respec-
tively. The module achieved an AUC value of 0.82, indicating
that it is able to accurately model the methylation patterns. In
this case, best performance was obtained using the polynomial
kernel of sixth degree, clearly depicting the complexity of the
methylation patterns that could not be captured by linear clas-
siﬁers. The radial basis function (RBF) kernel with g = 0.1 also
performed similar to the polynomial kernel. The detailed
threshold dependent performance of the polynomial and
RBF kernels is shown in Table 1. A complete summary of
AUC value achieved with diﬀerent window sizes has been
shown in Fig. 2.Fig. 2. Performance of SVM-modules for the prediction of CpG
methylation in humans trained on diﬀerent window sizes. Prediction
performance of the SVM modules trained with fragments (window
size) varying from 9 to 89 in 10 nucleotides increases was analyzed
through a ROC analysis, and the relevant ROC curves appear plotted
on the ﬁgure. The AUC achieved by the SVM-based models at the
diﬀerent window sizes is also shown in the ﬁgure. ROC curves were
generated by plotting the average values of SE and 1-SP obtained
through 5-fold cross-validation (see Section 2.4 for details).
Table 2
Performance of the mammalian SVM module
Threshold SE SP ACC MCC
1.100 99.6 2.42 51.02 0.088
0.900 93.6 34.36 63.98 0.346
0.700 88.16 53.74 70.92 0.446
0.500 83.42 62.84 73.16 0.476
0.300 69.42 75.42 72.42 0.448
0.100 57.04 84 70.54 0.424
0.100 52.64 87.2 69.94 0.424
0.300 46.78 89.92 68.34 0.408
0.500 40.7 92.6 66.64 0.388
0.700 30.42 95.8 63.1 0.346
0.900 10.38 98.54 54.46 0.188
1.100 1.94 99.84 50.86 0.082
1.300 0.08 20 10.04 0.01
Italicised values show the performance at default threshold.
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mammalian data
Another SVM module was developed based on the mamma-
lian methylation patterns that include human, mouse and rat
methylation patterns. It was trained using patterns of 39-win-
dow size as it was proven previously that SVM modules based
on a 39-window size performed better than other window sizes
(Fig. 2). The performance of this module was evaluated using
5-fold cross-validation through threshold dependent and inde-
pendent measures. This module achieved an AUC of 0.80 on
the ROC analysis. The detailed performance of module in term
of SE, SP, ACC and MCC is shown in Table 2.
3.3. SVM module for the prediction of methylation sites in
vertebrates
Finally, another SVM module was developed from methyla-
tion patterns from vertebrates. The training and testing sets
were obtained from 4210 methylation patterns corresponding
to human, mouse, rat, chicken, etc. The detailed threshold
dependent performance of this module is shown in Table 3.
The performance of this module (AUC = 0.80) was similar to
that of the SVM module based on mammalian data but lower
than that of SVM modules based on human data (Fig. 3). The
lower performance of the mammalian- and vertebrate-speciﬁc
SVM modules as compared with the human-speciﬁc SVM
module may result from the fact that methylation patterns
are speciﬁc for each species. On the other hand, the small dif-
ferences between the performance of the mammalian- or verte-
brate-speciﬁc SVM modules and the human SVM modules are
due to the fact that most of the methylation patterns in the
training set corresponded to human (>60%).
3.4. Performance of the diﬀerent SVM modules in LOOCV
The performance of the SVM modules (trained with frag-
ments size of 39 residues) derived from human, mammalian
and vertebrate methylation patterns was also evaluated using
leave one out cross-validation (Figure S1). The performance
of all modules using LOOCV technique was better than in
the 5-fold cross-validation. The performance of SVM modules
based on human data was 0.84, that is, 0.02 better than the
performance obtained during 5-fold cross-validation. The bet-
ter performance of modules is explained by the larger size of
the training dataset during LOOCV as compared to 5-fold
cross-validation.Table 1
Performance of SVM modules trained on DNA methylation data from hum
Polynomial kernel (D = 6) Threshold
SE SP ACC MCC
99.88 1.02 50.42 0.062 1.200
96.34 18.72 57.54 0.24 1.000
88.9 53.98 71.42 0.458 0.800
83.94 64.12 74.06 0.49 0.600
72.74 77.34 75.06 0.504 0.400
65.26 83.18 74.22 0.494 0.200
61.52 85.56 73.54 0.486 0.000
56.08 88.56 72.3 0.472 0.200
50.02 91.1 70.54 0.452 0.400
41.58 94.38 67.98 0.422 0.600
23.24 97.16 60.2 0.304 0.800
6.64 99.32 52.98 0.158 1.000
Italicised values show the performance at default threshold.3.5. Comparison of SVM-based method with other machine
learning and statistical algorithms based classiﬁers
Recently, a few studies have shown that SVM yields better
results in classifying biological data than alternative machine
learning techniques [38–40]. In this study, we have analyzed
the prediction of the methylation sites in human data using
SVM along with other classiﬁers developed ex-professo and
based on ANN, Bayesian statistics, logistic regression, decision
trees and K-nearest neighbors algorithms. All these classiﬁers
were derived from the same dataset consisting of human
DNA fragments of 39 nucleotides (see Section 2). The average
identity between the fragments in the datasets consisting of
non-methylated fragments was 34.1%. Likewise, the identity
between the methylated fragments was around 34.5%. The
average identity between the methylated and non-methylated
fragments was 34.2%. The performance of the classiﬁers based
on alternative machine learning techniques is shown in Table
4. This performance was obtained using 5-fold cross-validation
at a default threshold where the sensitivity and speciﬁcity are
nearly equal. The accuracy of the SVM-based module was
5% and 7% higher than K-nearest neighbors and decision
trees, respectively. The diﬀerence in accuracy between the
SVM-based classiﬁer and those based on ANN, logistic regres-
sion and naı¨ve bayes classiﬁers was even larger (Table 4). The
SVM-based module is able to recognize 73% of the methyla-
tion sites (SE), i.e., nearly 5% higher than any of the classiﬁeran
RBF Kernel (g = 0.1)
SE SP ACC MCC
100 0.26 50.14 0.04
97.38 14.32 55.86 0.21
89.28 49.94 69.6 0.426
85 60.32 72.66 0.468
74.46 73.08 73.76 0.476
63.72 81.38 72.56 0.458
59.26 85.06 72.18 0.46
53.86 88.24 71.04 0.45
47.22 90.66 68.92 0.42
38.28 94.16 66.24 0.392
19.74 97.68 58.72 0.278
6.72 99.24 53 0.154
Table 3
Performance of the vertebrate SVM module
Threshold SE SP ACC MCC
1.200 99.84 0.92 50.38 0.054
1.000 96.06 18.38 57.24 0.228
0.800 89 53.04 71.02 0.45
0.600 84.94 62.52 73.74 0.488
0.400 73.46 74.46 73.94 0.478
0.200 60.52 83.72 72.14 0.454
0.000 56.08 86.08 71.1 0.44
0.200 51.38 88.86 70.12 0.434
0.400 46.16 91.36 68.78 0.42
0.600 38.12 94.42 66.3 0.394
0.800 22.92 97.06 60 0.296
1.000 5.76 99.38 52.58 0.146
1.200 0.82 99.86 50.34 0.05
Italicised values show the performance at default threshold.
Fig. 3. Comparison of the performance of SVM modules generated
from methylation patterns from diﬀerent sources. Figure shows the
ROC curves depicting the performance of diﬀerent SVM modules
based on (i) human, (ii) mammalian and (iii) vertebrate data sets. able 5
rediction of methylation sites in annotated human genes using the
ptimal SVM-based module
ields Exons Introns UTRs
umber 140335 106727 13148
CpGs/100 0.560 0.378 2.6
pGs/100 1.59 1.017 7.43
he number ﬁeld indicates the total number of exons, introns and
TRs. The MCpGs/100 and CpGs/100 are methylated and total
umber of CpGs, respectively, per 100 base pairs.
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trees and K-nearest neighbors classiﬁers were able to recognize
81% non-methylated sites (better than SVM) but failed to
recognize the methylation sites (<59%). Thus, in our hands
SVM clearly outperformed other machine learning and
statistical techniques for the prediction of methylation sites
in human.Table 4
Performance of classiﬁers predicting human methylation sites
Classiﬁer Threshold SE
SVM 0.400 72
ANN 0.30 68
Naı¨ve bayes (Bayesian statistics) 0.0 55
Logistic regression 0.0 60
IBk (K-nearest neighbors) 0.0 59
J48 (decision trees) 0.0 55
The performance was obtained on 5-fold cross validation.3.6. Genome-wide analysis of methylation sites in human
The SVM module trained on human methylation data was
applied on a dataset of 16583 known human genes obtained
from NCBI. In order to examine the distribution of methyla-
tion sites in diﬀerent gene structures, the module was sepa-
rately applied to the UTR, exonic and intronic regions of the
genes (Table 5). In brief, the results indicated that the content
of the methylated CpG per 100 nucleotides is higher in UTRs
(2.6), followed by exons (0.56) and introns (0.378). On the
other hand, the number of CpG nucleotides per 100 nucleo-
tides was also higher in UTRs as compared with intron and
exons. Based on this study, we have developed a web server
under the name of Methylator for the prediction of DNA
methylation at CpG dinucleotides in humans (http://
bio.dfci.harvard.edu/Methylator/). The site is meant to reduce
the load on experimental biologist locating the DNA methyla-
tion sites from the genomic data, and there are plans to release
a standalone version of the method in the near future. A
snapshot of the home page of the server and a representative
result are shown in Fig. 4.
3.7. Conclusion and limitations
In summary, we have developed an accurate method for the
prediction of regular CpG methylation patterns in humans,
which ought to assist biologists, reducing the load of cumber-
some experiments. Furthermore, using this method, we have
been able to carry out a genome wide prediction of methyla-
tion sites.
It has been noted that abnormal methylation patterns are
associated with various diseases, most importantly cancer
[20]. Speciﬁcally, in many tumors it has been observed that
there is overmethylation – and consequent silencing – of tumor
repressor genes [41]. Thus, it would be interesting to predict
such abnormal patterns of methylation, as one may anticipate
their potential clinical implications. That certain CpG islands
associated with speciﬁc genes are more prone to overmethyla-
tion than others has already been proven from the analysis of
the methylation aﬀecting hundred of genes following the
overexpression of DNMT (a speciﬁc DNA methylase) [42].T
P
o
F
N
M
C
T
U
nSP ACC MCC
.74 77.34 75.06 0.504
.02 67.74 67.88 0.3582
.76 65.44 60.64 0.2132
.8 62.86 61.82 0.2368
.02 81.14 70.08 0.4118
.58 80.96 68.3 0.378
Fig. 4. Methylator webserver. (A) Input web page. Users can enter nucleotide sequence in one of the standard formats such as GenBank, EMBL,
GCG, or plain format. The method provides the option of pasting the sequence in the text area or uploading the direct sequence ﬁle. All non-
standard characters except the four nucleotides bases adenine, guanine, cytosine and thymine will be ignored from the sequence. (B) Prediction results
of Methylator. The methylated cytosines are highlighted in red color and bold letters. Currently the server allows only for the prediction of the DNA
methylation from a single sequence, and there is a limit size of 50000 nucleotides per query. Only the best SVM module – trained on the basis of
human data – has been made available in this server.
M. Bhasin et al. / FEBS Letters 579 (2005) 4302–4308 4307Unfortunately, these studies did not yield the location of the
speciﬁc methylation sites. The availability of such abnormal
patterns of methylation will be a great interest, as it will em-
power our method to predict gene speciﬁc overmethylation
and anticipate their implications.
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